Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Prophylactic Reinforcement of Ventral Abdominal Incisions Trial
NCT03911700 · View on ClinicalTrials.gov ↗
Study Summary
This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
Conditions Studied
Interventions
- DEVICE Phasix™ Mesh
Study Locations (20)
Missouri
- St. Luke's Hospital — Kansas City
- Cox Health — Springfield
- Washington University — St Louis
California
- Keck Medical Center of USC — Los Angeles
- University of California San Francisco — San Francisco
Connecticut
- Hartford Hospital — Hartford
- St. Francis Hospital and Medical Center — Hartford
Minnesota
- Minneapolis VA Health Care System — Minneapolis
- University of Minnesota — Minneapolis
Nebraska
- Nebraska Medical Center — Omaha
- Nebraska Methodist Hospital — Omaha
Arizona
- Dignity Health — Phoenix
Georgia
- Emory University — Atlanta
Illinois
- OSF Saint Francis Medical Center — Peoria
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 477 participants |
| Start Date | 2019-12-12 |
| Est. Completion | 2031-12 |
| Phase | NA |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03911700
The ClinicalTrials.gov registry entry for NCT03911700 describes a study currently listed as recruiting. It is categorized as NA, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 477 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is C. R. Bard, which has 46 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Open Midline Laparotomy appearing as the primary indexed condition, and to 1 intervention — of which Phasix™ Mesh is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT03911700 reports 20 study locations spanning 14 distinct geographic areas — top geographies include Missouri, California, Connecticut. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT03911700 about?
NCT03911700 is a clinical study titled "Prophylactic Reinforcement of Ventral Abdominal Incisions Trial". This trial is being conducted to evaluate the efficacy of Phasix™ Mesh implantation at the time of midline fascial closure compared to primary suture closure in preventing a subsequent incisional hernia in subjects at risk for incisional hernia after open midline laparotomy surgery.
What is the current status of trial NCT03911700?
This trial is currently recruiting. It is a NA study. The enrollment target is 477 participants. The study started on 2019-12-12. Estimated completion is 2031-12.
What conditions does trial NCT03911700 study?
This clinical trial studies the following conditions: Open Midline Laparotomy. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT03911700?
The interventions under investigation include: Phasix™ Mesh (DEVICE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT03911700?
This trial is sponsored by C. R. Bard, which has 46 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT03911700 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Georgia, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.